The Blog

Collaborative Neuroscience Network Receives Certificate of Achievement from IQVIA

Site Recognition Award commemorates exceptional performance of Collaborative Neuroscience Network.

Read More

David Walling, PhD Discusses Misconceptions and New Developments Around Schizophrenia in Interview with MD Magazine

At the American Psychiatric Associations’ annual meeting in New York City, David Walling, PhD, CEO and Principal Investigator for Collaborative Neuroscience Network, sat down with MD Magazine to talk about the biggest misconceptions about patients with schizophrenia—including the high rate of suicide among this patient population—and what’s being done to address them. He also spoke…

Read More

Upcoming Conferences: SIRS, APA, and ASCP

April 4-8, Alliance representatives are attending the Schizophrenia International Research Society (SIRS) Conference in Florence, Italy.   May 5-9, we’ll be in New York City for the American Psychiatric Association (APA) Annual Meeting.   May 28-June 1, we’re attending the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, Florida.   We look forward…

Read More

Link to Dr. Gary Kay’s Webinar: “Evaluating Your Compound’s Impact on Driving”

Check out the recording of Dr. Gary Kay’s recent webinar, “Evaluating Your Compound’s Impact on Driving.” (Skip to the three-minute mark for the beginning of the webinar.) In this informative webinar, Cognitive Research Corporation‘s President, Gary Kay, Ph.D., assists you in understanding and implementing FDA requirements for evaluating your compound’s impact on driving. An expert…

Read More

Don’t Let Translations Slow Down Your Trial

  Don’t Let Translations Slow Down Your Trial Accelerate It With Accurate, On-Time Translations Get Your Quote in 24hrs or Less! Rely on a company that understands your study’s cultural and scientific nuances without sacrificing the deadline. No matter your timeline, timezone, or language, NCT Linguistics can provide your team with 100% accurate and on-time…

Read More

2018 Conference Date eCards from the Alliance

As we ring in the new year, we’ve identified some prominent industry conferences in 2018, and added the dates and locations to our annual e-card for your reference. With our Alliance’s growth, we now have a CNS-focused card and a medical version. Both are included below. Alliance principals and partners are presenting at and attending…

Read More

Poster accepted for ISCTM in February

Our Alliance group is proud to announce that one of our sites, Hassman Research Institute (HRI), was recently accepted to present their empirical research poster at the International Society for CNS Clinical Trials and Methodology (ISCTM) Conference on Wednesday, 21 February 2018, 6:00 – 7:30 pm EST. If you are attending ISCTM in 2018, please…

Read More

Congratulations to Sage Therapeutics

Sage Therapeutics Reports Positive Top-line Results from Phase 2 Placebo-Controlled Trial of SAGE-217 in Major Depressive Disorder   – SAGE-217 met primary endpoint and provided rapid, profound and durable effects through 2-week treatment period and additional 4-week follow-up – – Well-tolerated and demonstrated highly statistically significant mean reduction in the HAM-D score compared to placebo…

Read More
Page 1 of 712 »